Piperaquine
Piperaquine is an antimalarial drug that is often used in combination with other drugs, such as artemisinin, to treat malaria. It is a bisquinoline, part of a family of drugs that also includes chloroquine and quinine, which have been used for many years to prevent and treat malaria.
History
Piperaquine was first synthesized in the 1960s and was widely used in China and Cambodia during the 1970s and 1980s as a first-line treatment for malaria. However, its use declined in the 1990s due to the emergence of resistance. In recent years, it has been reintroduced in combination with artemisinin, a potent and rapidly acting antimalarial drug.
Mechanism of Action
Piperaquine works by interfering with the parasite's ability to break down and digest hemoglobin. This leads to the accumulation of toxic heme, which kills the parasite. The exact mechanism of action is not fully understood, but it is thought to involve inhibiting the formation of hemozoin, a substance produced by the parasite to detoxify heme.
Use in Combination Therapy
The combination of piperaquine and artemisinin, known as artemisinin-based combination therapy (ACT), is currently recommended by the World Health Organization (WHO) as a first-line treatment for uncomplicated Plasmodium falciparum malaria. ACTs are highly effective and have contributed significantly to the reduction of malaria cases and deaths in recent years.
Side Effects
Like all medicines, piperaquine can cause side effects, although not everybody gets them. Common side effects include headache, dizziness, loss of appetite, nausea, vomiting, abdominal pain, and rash. Serious side effects are rare but can include changes in heart rhythm, liver problems, and severe allergic reactions.
Resistance
Resistance to piperaquine has been reported in some areas, particularly in Southeast Asia. This is a major concern as it threatens the effectiveness of ACTs. Ongoing surveillance and research are needed to monitor the situation and develop new treatments.
See Also
Ad. Transform your life with W8MD's Budget GLP-1 injections from $29.99


W8MD offers medical weight loss programs including NYC medical weight loss and Philadelphia medical weight loss offering:
- Affordable GLP1 shots (generic and brand names) such as
- Wegovy NYC (Semaglutide)
- Zepbound NYC /
- Learn more: Budget GLP1 weight loss injections NYC & Philadelphia GLP1 weight loss shots
- Most insurances accepted
- Lowest cost GLP1 weight loss NYC such as Semaglutide starting from $29.99/week and $45.00/week (Tirzepatide) with insurance.
- Prescription weight loss NYC including:
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your physician weight loss journey today at our:
- NYC medical weight loss
- Philadelphia medical weight loss
- Call 718-946-5500 for NYC or 215-676-2334 for Philadelphia
- Tags:
Budget glp1 weight loss NYC,
Zepbound NYC,
Philadelphia medical weight loss,
Wegovy NYC,
Zepbound Philadelphia,
Budget GLP1 shots Philadelphia
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


